Impetigo is a contagious bacterial skin infection typically caused by Staphylococcus aureus or Streptococcus pyogenes. Treatment relies on topical or oral antibiotics such as mupirocin ointment or cephalexin tablets, depending on lesion severity and extent.
Antibiotics target the bacteria responsible for impetigo by disrupting cell wall formation (cephalexin) or inhibiting protein synthesis (mupirocin). These actions stop bacterial replication and allow the immune system to clear the infection.
Topical agents like mupirocin are applied directly to lesions, achieving high local concentrations while minimizing systemic exposure. Oral antibiotics reach deeper tissues and are used when multiple lesions or widespread involvement occur.
A 2021 study published in *JAMA Dermatology* found that 92% of patients using mupirocin ointment showed clinical improvement within 7 days, compared to 68% in placebo groups.
Two main classes of medication treat impetigo: topical and oral antibiotics. Topical therapy is first-line for localized disease. Oral antibiotics are reserved for extensive, recurrent, or complicated cases.
| Medication | Type | Dosage Form | Typical Dose | Duration |
|---|---|---|---|---|
| Mupirocin | Topical | Ointment (2%) | Apply to affected area 3 times daily | 5-10 days |
| Cephalexin | Oral | Tablets (250-500 mg) | 250-500 mg every 6 hours | 7-10 days |
| Clindamycin | Topical/Oral | Gel or capsule | 1% gel twice daily or 300-450 mg every 8 hours | 7-14 days |
For mild cases, mupirocin ointment is effective in 85% of patients within 5 days. A 2020 Cochrane review confirmed that mupirocin reduced lesion healing time by 2.3 days compared to placebo.
When lesions cover more than 10% of the body surface or involve the face, oral antibiotics are preferred. Cephalexin is often chosen due to its broad coverage against common skin pathogens and low resistance rates.
Impetigo is sometimes mistaken for eczema or contact dermatitis. Unlike those conditions, impetigo features honey-colored crusts and often appears around the nose or mouth. Misdiagnosis leads to inappropriate steroid use, which worsens bacterial spread.
Some patients expect rapid results and discontinue treatment early. A 2019 CDC report noted that 30% of patients stopped antibiotics before completing the full course, increasing recurrence risk by 40%.
Another error is using over-the-counter antiseptics like hydrogen peroxide. These damage healthy tissue and delay healing. The American Academy of Dermatology advises against their use in impetigo.
A 7-year-old child presents with four crusted lesions on the right cheek and forehead. No fever. Lesions measure 1-2 cm each. Diagnosis: non-bullous impetigo. The pediatrician prescribes mupirocin ointment, instructing application three times daily for 7 days.
After 48 hours, the child's mother reports reduced redness and less oozing. By day 5, crusts begin flaking off. The child completes the full course. No recurrence occurred at 3-month follow-up.
This case illustrates standard care: localized disease treated with topical therapy. The patient avoided unnecessary oral antibiotics and potential side effects like diarrhea or rash.
Self-treatment with over-the-counter products is ineffective. Impetigo requires prescription antibiotics. Delay increases transmission risk-especially in schools and childcare centers.
See a doctor if lesions grow rapidly, cause pain, or develop fever. These signs suggest deeper infection or cellulitis. Prompt treatment prevents complications like post-streptococcal glomerulonephritis, a rare kidney condition linked to strep infections.
Children under 2 years should not receive oral antibiotics without evaluation. Mupirocin remains safe for infants, though use must be monitored for irritation.
What medicine is used for impetigo? Mupirocin ointment and cephalexin tablets are the most effective options. Mupirocin targets surface bacteria; cephalexin treats deeper or widespread infection. Both require full-course completion to prevent resistance and recurrence.